1. Baraldini M, Miglio F, Pirillo L, Cursaro C, Meliconi R, Stefanini GF, Gasbarrini G (1983) Hepatitis B virus markers in hematologic patients: relation to transfusion treatment and hospitalization. Vox Sang 45:112?120
2. Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P (1981) Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II. Haemodialysis patients. Lancet I:797?800
3. Deinhardt F (1983) Suggested immunization programs with hepatitis B vaccine for high-risk groups. In: Papaevangelou G, Hennessen W (eds) Developments in biological standardization 54: Viral hepatitis: Standardization in immunoprophylaxis of infections by hepatitis viruses. S Karger, Basel Munich Paris London New York Sydney, pp 307?309
4. Goldblum SE, Reed WP (1980) Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93:597?613
5. Goudeau A, Dubois F, Barin F, Dubois MC, Coursaget P (1983) Hepatitis B vaccine: clinical trials in high-risk settings in France. In: Papaevangelou G, Hennessen W (eds) Developments in biological standardardization 54: Viral hepatitis: Standardization in immunoprophylaxis of infections by hepatitis viruses. S Karger, Basel Munich Paris London New York Sydney, pp 267?284